180 related articles for article (PubMed ID: 37868966)
1. Case Report: Methotrexate and hydroxychloroquine in combination for the treatment of NOD2-mutation-associated Blau syndrome.
Jensen ME; Harrell K; McBride JD
Front Immunol; 2023; 14():1279329. PubMed ID: 37868966
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation in early-onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes.
Okazaki F; Wakiguchi H; Korenaga Y; Nakamura T; Yasudo H; Uchi S; Yanai R; Asano N; Hoshii Y; Tanabe T; Izawa K; Honda Y; Nishikomori R; Uchida K; Eishi Y; Ohga S; Hasegawa S
Pediatr Rheumatol Online J; 2021 Feb; 19(1):18. PubMed ID: 33602264
[TBL] [Abstract][Full Text] [Related]
3. Blau Syndrome With Delayed Cutaneous Manifestations: A Case Report.
Panah E; Garfield E; Zahirsha Z; Muhlbauer A; Lake E; Speiser J
Am J Dermatopathol; 2024 Jun; 46(6):381-382. PubMed ID: 38648024
[TBL] [Abstract][Full Text] [Related]
4. Sporadic Blau syndrome with onset of widespread granulomatous dermatitis in the newborn period.
Stoevesandt J; Morbach H; Martin TM; Zierhut M; Girschick H; Hamm H
Pediatr Dermatol; 2010; 27(1):69-73. PubMed ID: 20199415
[TBL] [Abstract][Full Text] [Related]
5. Blau syndrome: Lessons learned in a tertiary care centre at Chandigarh, North India.
Kumrah R; Pilania RK; Menia NK; Rawat A; Sharma J; Gupta A; Vignesh P; Jindal AK; Rikhi R; Agarwal A; Gupta V; Singh S; Suri D
Front Immunol; 2022; 13():932919. PubMed ID: 36189202
[TBL] [Abstract][Full Text] [Related]
6. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort.
Aróstegui JI; Arnal C; Merino R; Modesto C; Antonia Carballo M; Moreno P; García-Consuegra J; Naranjo A; Ramos E; de Paz P; Rius J; Plaza S; Yagüe J
Arthritis Rheum; 2007 Nov; 56(11):3805-13. PubMed ID: 17968944
[TBL] [Abstract][Full Text] [Related]
7. [Blau syndrome--a chronic granulomatous, genetic disease].
Milman N; Byg KE
Ugeskr Laeger; 2006 Oct; 168(42):3612-4. PubMed ID: 17069723
[TBL] [Abstract][Full Text] [Related]
8. Blau syndrome with a rare mutation in exon 9 of
Velickovic J; Silan F; Bir FD; Silan C; Albuz B; Ozdemir O
Autoimmunity; 2019; 52(7-8):256-263. PubMed ID: 31556326
[TBL] [Abstract][Full Text] [Related]
9. A Novel Mutation in Helical Domain 2 of NOD2 in Sporadic Blau Syndrome.
Jain L; Gupta N; Reddy MM; Mittal R; Barik MR; Panigrahi B; Monie T; Basu S
Ocul Immunol Inflamm; 2018; 26(2):292-294. PubMed ID: 27625029
[TBL] [Abstract][Full Text] [Related]
10. A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members.
Milman N; Ursin K; Rødevand E; Nielsen FC; Hansen TV
Scand J Rheumatol; 2009; 38(3):190-7. PubMed ID: 19169908
[TBL] [Abstract][Full Text] [Related]
11. Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome).
Carreño E; Guly CM; Chilov M; Hinchcliffe A; Arostegui JI; Lee RW; Dick AD; Ramanan AV
Acta Ophthalmol; 2015 May; 93(3):253-7. PubMed ID: 25209167
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the
Matsuda T; Kambe N; Ueki Y; Kanazawa N; Izawa K; Honda Y; Kawakami A; Takei S; Tonomura K; Inoue M; Kobayashi H; Okafuji I; Sakurai Y; Kato N; Maruyama Y; Inoue Y; Otsubo Y; Makino T; Okada S; Kobayashi I; Yashiro M; Ito S; Fujii H; Kondo Y; Okamoto N; Ito S; Iwata N; Kaneko U; Doi M; Hosokawa J; Ohara O; Saito MK; Nishikomori R; ;
Ann Rheum Dis; 2020 Nov; 79(11):1492-1499. PubMed ID: 32647028
[TBL] [Abstract][Full Text] [Related]
13. Widespread granulomatous dermatitis of infancy: an early sign of Blau syndrome.
Schaffer JV; Chandra P; Keegan BR; Heller P; Shin HT
Arch Dermatol; 2007 Mar; 143(3):386-91. PubMed ID: 17372104
[TBL] [Abstract][Full Text] [Related]
14. Lipogranulomatous subconjunctival nodules: a novel presentation in Blau syndrome.
Ahmad M; Hermanson ME; Enzenauer R; Palestine A; Lin C; Meeks N; McCourt E
J AAPOS; 2017 Jun; 21(3):249-251. PubMed ID: 28532706
[TBL] [Abstract][Full Text] [Related]
15. A Novel Pathogenic
Rodrigues FG; Petrushkin H; Webster AR; Bickerstaff M; Moraitis E; Rowczenio D; Aróstegui JI; Westcott M
Ophthalmic Genet; 2021 Dec; 42(6):753-764. PubMed ID: 34251956
[TBL] [Abstract][Full Text] [Related]
16. Unique Variant of NOD2 Pediatric Granulomatous Arthritis With Severe 1,25-Dihydroxyvitamin D-Mediated Hypercalcemia and Generalized Osteosclerosis.
Whyte MP; Lim E; McAlister WH; Gottesman GS; Trinh L; Veis DJ; Bijanki VN; Boden MG; Nenninger A; Mumm S; Buchbinder D
J Bone Miner Res; 2018 Nov; 33(11):2071-2080. PubMed ID: 29933504
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide may be an effective drug for Blau syndrome: a case report.
Wang W; Wang W; Zhong LQ; Li WD; Wu SJ; Song HM
Ann Palliat Med; 2022 Jul; 11(7):2538-2543. PubMed ID: 34775778
[TBL] [Abstract][Full Text] [Related]
18. Manifestation of Panuveitis after Intraocular Surgery in a Child with Blau Syndrome.
Magliyah MS; Khan AM; AlShamrani M; Schatz P; Dhibi HA
Middle East Afr J Ophthalmol; 2021; 28(3):196-198. PubMed ID: 35125805
[TBL] [Abstract][Full Text] [Related]
19. Genetic and Clinical Features of Blau Syndrome among Chinese Patients with Uveitis.
Zhong Z; Ding J; Su G; Liao W; Gao Y; Zhu Y; Deng Y; Li F; Du L; Gao Y; Yang P
Ophthalmology; 2022 Jul; 129(7):821-828. PubMed ID: 35314268
[TBL] [Abstract][Full Text] [Related]
20. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.
Okafuji I; Nishikomori R; Kanazawa N; Kambe N; Fujisawa A; Yamazaki S; Saito M; Yoshioka T; Kawai T; Sakai H; Tanizaki H; Heike T; Miyachi Y; Nakahata T
Arthritis Rheum; 2009 Jan; 60(1):242-50. PubMed ID: 19116920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
